tetradecanoylphorbol acetate and Diabetic Neuropathies

tetradecanoylphorbol acetate has been researched along with Diabetic Neuropathies in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chattopadhyay, M; Fink, DJ; Mata, M	1
Ihm, SH; Park, CJ; Park, SW; Yoo, HJ	1
Cha, DR; Cho, BS; Ha, H; Hong, SP; Ihm, CG; Kim, MJ; Lee, TW; Park, JK	1
Greene, DA; Lattimer, SA; Sima, AA	1
Greene, DA; Lattimer, SA	1

Trials

1 trial(s) available for tetradecanoylphorbol acetate and Diabetic Neuropathies

Article	Year
Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:6 Topics: Aldehyde Reductase; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Naphthalenes; Neutrophils; Reference Values; Regression Analysis; Respiratory Burst; Tetradecanoylphorbol Acetate	1997

Article

Year

Effect of tolrestat, an aldose reductase inhibitor, on neutrophil respiratory burst activity in diabetic patients.

Metabolism: clinical and experimental, 1997, Volume: 46, Issue:6

Topics: Aldehyde Reductase; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Enzyme Inhibitors; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Naphthalenes; Neutrophils; Reference Values; Regression Analysis; Respiratory Burst; Tetradecanoylphorbol Acetate

1997

Other Studies

4 other study(ies) available for tetradecanoylphorbol acetate and Diabetic Neuropathies

Article	Year
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Jun-25, Volume: 28, Issue:26 Topics: Animals; Cells, Cultured; Diabetic Neuropathies; Down-Regulation; Enkephalins; Enzyme Activation; Enzyme Inhibitors; Ganglia, Spinal; Genetic Vectors; Hyperglycemia; Male; Narcotic Antagonists; NAV1.7 Voltage-Gated Sodium Channel; Neurons, Afferent; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C; Rats; Receptors, Opioid, delta; Sodium Channels; Tetradecanoylphorbol Acetate; Transfection	2008
A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron, 1998, Volume: 79, Issue:1 Topics: Cells, Cultured; Chemokine CCL2; Diabetic Neuropathies; Enzyme Inhibitors; Gene Expression Regulation; Glomerular Mesangium; Glucose; Humans; Monocytes; Naphthalenes; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate	1998
In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists. The American journal of physiology, 1989, Volume: 256, Issue:2 Pt 1 Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diglycerides; Kinetics; Male; Ouabain; Protein Kinase C; Rabbits; Reference Values; Sciatic Nerve; Sodium-Potassium-Exchanging ATPase; Tetradecanoylphorbol Acetate	1989
Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications. Diabetes, 1986, Volume: 35, Issue:2 Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diglycerides; Glycerides; Inositol; Male; Ouabain; Oxygen Consumption; Peripheral Nerves; Phorbols; Protein Kinase C; Rabbits; Rats; Sodium-Potassium-Exchanging ATPase; Tetradecanoylphorbol Acetate	1986